These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 21996278

  • 1. Genetic epistasis between the brain-derived neurotrophic factor Val66Met polymorphism and the 5-HTT promoter polymorphism moderates the susceptibility to depressive disorders after childhood abuse.
    Grabe HJ, Schwahn C, Mahler J, Appel K, Schulz A, Spitzer C, Fenske K, Barnow S, Freyberger HJ, Teumer A, Petersmann A, Biffar R, Rosskopf D, John U, Völzke H.
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar 30; 36(2):264-70. PubMed ID: 21996278
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Genetic susceptibility to family environment: BDNF Val66met and 5-HTTLPR influence depressive symptoms.
    Dalton ED, Hammen CL, Najman JM, Brennan PA.
    J Fam Psychol; 2014 Dec 30; 28(6):947-56. PubMed ID: 25347540
    [Abstract] [Full Text] [Related]

  • 5. Interactions between childhood maltreatment and brain-derived neurotrophic factor and serotonin transporter polymorphisms on depression symptoms.
    Harkness KL, Strauss J, Michael Bagby R, Stewart JG, Larocque C, Mazurka R, Ravindran A, Wynne-Edwards KE, Rector NA, Kennedy J.
    Psychiatry Res; 2015 Sep 30; 229(1-2):609-12. PubMed ID: 26070769
    [Abstract] [Full Text] [Related]

  • 6. Genotypes do not confer risk for delinquency but rather alter susceptibility to positive and negative environmental factors: gene-environmentinteractions of BDNF Val66Met, 5-HTTLPR, and MAOA-uVNTR [corrected].
    Nilsson KW, Comasco E, Hodgins S, Oreland L, Åslund C.
    Int J Neuropsychopharmacol; 2014 Dec 10; 18(5):. PubMed ID: 25522433
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effect of childhood trauma on serum BDNF in bipolar depression is modulated by the serotonin promoter genotype.
    Benedetti F, Ambrée O, Locatelli C, Lorenzi C, Poletti S, Colombo C, Arolt V.
    Neurosci Lett; 2017 Aug 24; 656():177-181. PubMed ID: 28754344
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Interacting effect of BDNF Val66Met polymorphism and stressful life events on adolescent depression.
    Chen J, Li X, McGue M.
    Genes Brain Behav; 2012 Nov 24; 11(8):958-65. PubMed ID: 22931410
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The BDNF Val66Met polymorphism is associated with rumination in healthy adults.
    Beevers CG, Wells TT, McGeary JE.
    Emotion; 2009 Aug 24; 9(4):579-84. PubMed ID: 19653783
    [Abstract] [Full Text] [Related]

  • 17. The risk for major depression conferred by childhood maltreatment is multiplied by BDNF and SERT genetic vulnerability: a replication study.
    Gutiérrez B, Bellón JÁ, Rivera M, Molina E, King M, Marston L, Torres-González F, Moreno-Küstner B, Moreno-Peral P, Motrico E, Montón-Franco C, GildeGómez-Barragán MJ, Sánchez-Celaya M, Díaz-Barreiros MÁ, Vicens C, de Dios Luna J, Nazareth I, Cervilla J.
    J Psychiatry Neurosci; 2015 May 24; 40(3):187-96. PubMed ID: 25510949
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Impact of 5-HTTLPR and BDNF polymorphisms on response to sertraline versus transcranial direct current stimulation: implications for the serotonergic system.
    Brunoni AR, Kemp AH, Shiozawa P, Cordeiro Q, Valiengo LC, Goulart AC, Coprerski B, Lotufo PA, Brunoni D, Perez AB, Fregni F, Benseñor IM.
    Eur Neuropsychopharmacol; 2013 Nov 24; 23(11):1530-40. PubMed ID: 23615118
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.